2011
DOI: 10.1002/14651858.cd002256.pub2
|View full text |Cite
|
Sign up to set email alerts
|

Treatments for symptomatic urinary tract infections during pregnancy

Abstract: Analysis 2.1. Comparison 2 Intravenous and oral cephradine versus intravenous and oral cefuroxime, Outcome 1 Cure rates...... Analysis 2.2. Comparison 2 Intravenous and oral cephradine versus intravenous and oral cefuroxime, Outcome 2 Recurrent infection..

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
42
0
18

Year Published

2011
2011
2019
2019

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 91 publications
(61 citation statements)
references
References 29 publications
1
42
0
18
Order By: Relevance
“…Clearly, also, clinicians are rightly loth to give complex and potentially teratogenic treatments to pregnant women when this can be avoided (11341137). However, the surprising lack of systematic data with antibiotics (1138), modulo one particularly spectacular success (540), suggests that we ought to be performing trials with safe antibiotics on women at special risk (1139). These must take care to avoid any Jarisch–Herxheimer reaction (11401143) due to the release from microbes induced by antibiotics of inflammagens such as LPS (11441147).…”
Section: Prevention Strategiesmentioning
confidence: 99%
“…Clearly, also, clinicians are rightly loth to give complex and potentially teratogenic treatments to pregnant women when this can be avoided (11341137). However, the surprising lack of systematic data with antibiotics (1138), modulo one particularly spectacular success (540), suggests that we ought to be performing trials with safe antibiotics on women at special risk (1139). These must take care to avoid any Jarisch–Herxheimer reaction (11401143) due to the release from microbes induced by antibiotics of inflammagens such as LPS (11441147).…”
Section: Prevention Strategiesmentioning
confidence: 99%
“…Clearly, too, clinicians are rightly loth to give complex and potentially teratogenic treatments to pregnant women when this can be avoided [1064; 1065]. However, the surprising lack of systematic data with antibiotics [1066], modulo one particularly spectacular success [521], suggests that we ought to be performing trials with safe antibiotics on women at special risk [1067]. These must take care to avoid any Jarisch-Herxheimer reaction [10681070] due to the release from microbes induced by antibiotics of inflammagens like LPS [10711074].…”
Section: Clotting Coagulopathies and Fibrinogen In Pementioning
confidence: 99%
“…The most common adverse condition during pregnancy is urinary tract infections [62]. It causes more symptoms than other conditions and may lead to maternal and neonatal morbidity and mortality [63]. Diseases of the lower urinary tract occurring during pregnancy lead to more symptoms than other conditions.…”
Section: Introductionmentioning
confidence: 99%